| Title : Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression - Farlow_2001_Arch.Neurol_58_417 |
| Author(s) : Farlow MR , Hake A , Messina J , Hartman R , Veach J , Anand R |
| Ref : Archives of Neurology , 58 :417 , 2001 |
| Abstract : |
| PubMedSearch : Farlow_2001_Arch.Neurol_58_417 |
| PubMedID: 11255445 |
| Title : Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease - Potkin_2001_Int.J.Neuropsychopharmacol_4_223 |
| Author(s) : Potkin SG , Anand R , Fleming K , Alva G , Keator D , Carreon D , Messina J , Wu JC , Hartman R , Fallon JH |
| Ref : Int J Neuropsychopharmacol , 4 :223 , 2001 |
| Abstract : |
| PubMedSearch : Potkin_2001_Int.J.Neuropsychopharmacol_4_223 |
| PubMedID: 11602028 |
| Title : An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors - Kumar_2000_Eur.J.Neurol_7_159 |
| Author(s) : Kumar V , Anand R , Messina J , Hartman R , Veach J |
| Ref : Eur Journal of Neurology , 7 :159 , 2000 |
| Abstract : |
| PubMedSearch : Kumar_2000_Eur.J.Neurol_7_159 |
| PubMedID: 10809936 |